Bhadhuri, Arjun, Ralph Insinga, Patrik Guggisberg, Cedric Panje, and Matthias Schwenkglenks. 2019. “Cost Effectiveness of Pembrolizumab Vs Chemotherapy As First-Line Treatment for Metastatic NSCLC That Expresses High Levels of PD-L1 in Switzerland”. Swiss Medical Weekly 149 (5152):w20170. https://doi.org/10.4414/smw.2019.20170.